1. Denosumab biosimilar (LY06006) in Chinese postmenopausal osteoporotic women: A randomized, double-blind, placebo-controlled, multicenter phase III study
- Author
-
Gu, Jiemei, primary, Zhang, Hao, additional, Xue, Qingyun, additional, Wang, Li, additional, Cheng, Zhifeng, additional, Zhang, Yawei, additional, Li, Qifu, additional, Yuan, Lingqing, additional, Li, Yukun, additional, Dong, Jin, additional, Huo, Yanan, additional, Tang, Xin, additional, Hu, Ling, additional, Wang, Xinjia, additional, Hua, Fei, additional, Shen, Lin, additional, Cheng, Jinluo, additional, Zhou, Huimin, additional, Xu, Youjia, additional, Yang, Tao, additional, Wang, Chuansuo, additional, Xu, Jin, additional, Shen, Jie, additional, Zhang, Ying, additional, Zhang, Xiaomei, additional, Hong, Dun, additional, Guan, Xiaoling, additional, Xiao, Xinhua, additional, Wang, Guang, additional, Liu, Yonghua, additional, Fu, Liujun, additional, Chen, Jianting, additional, Cheng, Xigao, additional, Ding, Yue, additional, Liu, Lijun, additional, Yao, Qi, additional, Zhang, Xinchao, additional, Li, Lixin, additional, Zhang, Panjun, additional, Deng, Chunying, additional, Jiang, Chengyan, additional, You, Li, additional, Wang, Kai, additional, Zhang, Shimin, additional, Xiao, Jianzhong, additional, Liu, Wei, additional, Du, Xiaohong, additional, Shang, Xianwen, additional, Pan, Tianrong, additional, Lei, Chen, additional, Guo, Shuren, additional, and Zhang, Zhenlin, additional
- Published
- 2023
- Full Text
- View/download PDF